Replimune (REPL) Debt Ratio (2023 - 2025)
Replimune's (REPL) quarterly Debt Ratio came in at 0.14 in Q4 2025, up 87.52% year-on-year from 0.08 in Q4 2024, and up 17.79% quarter-over-quarter from 0.12 in Q3 2025.
Replimune (REPL) Debt Ratio (2023 - 2025) Analysis & Trends
Replimune has disclosed Debt Ratio across 3 years of filings, most recently posting 0.14 for Q4 2025.
- Debt Ratio for Q4 2025 came in at 0.14, up 87.52% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.14 (up 87.52% YoY), and the FY2025 annual result was 0.08, down 8.44% from the prior year.
- Debt Ratio came in at 0.14 for Q4 2025 at Replimune, up from 0.12 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.14 in Q4 2025 to a low of 0.04 in Q1 2023.
- The 3-year median for Debt Ratio is 0.09 (2024), against an average of 0.09.
- Across the five-year window, Debt Ratio surged 107.36% in 2024 and declined 8.44% in 2025, its largest moves.
- Replimune's Debt Ratio stood at 0.04 in 2023, then surged by 71.85% to 0.08 in 2024, then soared by 87.52% to 0.14 in 2025.
- The last three Debt Ratio figures came in at 0.14 (Q4 2025), 0.12 (Q3 2025), and 0.1 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.18 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Replimune | 848.00 Mn | 578.86 Mn | - | 0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.14 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | 0.10 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.08 |
| Sep 30, 2024 | 0.09 |
| Jun 30, 2024 | 0.08 |
| Mar 31, 2024 | 0.09 |
| Mar 31, 2023 | 0.04 |